Can't Find Wegovy? The 5 Best Alternatives You Can Get Right Now

If you're one of the millions of Americans driving from pharmacy to pharmacy trying to fill a prescription for Wegovy, you already know the frustration. The medication, a once-weekly injection that has revolutionized the treatment of obesity, has been in chronic short supply for over a year. Novo Nordisk simply cannot manufacture the proprietary injector pens fast enough.

But pausing your treatment isn't just frustrating; it can reverse months of hard-earned progress. Clinical data shows that when patients stop taking GLP-1 medications like Wegovy, they typically regain two-thirds of the lost weight within a year.

The good news? Because the FDA has declared an official shortage, you don't have to wait for Novo Nordisk. Federal law allows specialized compounding pharmacies to create the exact same medication. Here are the 5 best alternatives to brand-name Wegovy that you can access right now.

1

Compounded Semaglutide

If you want the exact same active ingredient that is in Wegovy, compounded semaglutide is your direct replacement. It is legally produced by state-licensed compounding pharmacies because of the FDA shortage.

2

Compounded Tirzepatide

What if you could switch to an alternative that is actually more effective than Wegovy? Tirzepatide is the active ingredient in Mounjaro and Zepbound, and it is currently the most powerful weight loss drug on the market.

3

Brand-Name Zepbound

If your commercial insurance covers weight loss medications and you absolutely refuse to use a compounded alternative, Zepbound is your best bet.

Why it works: This is the FDA-approved brand name for tirzepatide when prescribed for obesity. It comes in a highly convenient, single-use auto-injector pen.

The Catch: The out-of-pocket retail price is over $1,050 per month. Most insurance companies will not cover it, and even if they do, you will likely encounter the exact same frustrating pharmacy shortages that you experienced with Wegovy.

4

Liraglutide (Saxenda)

Saxenda is the older sibling to Wegovy. It was the first GLP-1 medication approved specifically for weight loss.

Why it works: Because it is an older drug, the viral demand is lower, meaning it is occasionally easier to find in stock at your local retail pharmacy than Wegovy or Zepbound.

The Catch: It requires a daily injection instead of a weekly one, and it is significantly less effective (patients lose about 5% to 8% of their body weight). At a retail price of roughly $1,300 a month, it is an extremely poor value unless your insurance covers it entirely.

5

Oral Semaglutide (Rybelsus)

For those who are completely terrified of needles, the active ingredient in Wegovy is available in a daily pill.

Why it works: It's a pill! You take it once a day.

The Catch: It is only FDA-approved for Type 2 diabetes, meaning insurance will rarely cover it for weight loss. Furthermore, the absorption in the stomach is highly inefficient. You have to take it on an empty stomach with a tiny sip of water and wait 30 minutes before eating or drinking anything else. For a fraction of the cost, the weekly compounded injections are vastly more effective and reliable.

The Hidden Cost of the Wegovy Shortage

When Novo Nordisk launched Wegovy, it triggered a cultural phenomenon. Suddenly, a safe, highly effective medication was available that could help individuals lose 15% or more of their body weight without invasive bariatric surgery. However, the ensuing demand was unprecedented in modern pharmaceutical history. The primary bottleneck is not the active ingredient (semaglutide) itself, but the highly specialized, proprietary single-use auto-injector pens used to deliver the medication.

This shortage has created a massive hidden cost for consumers. Patients who manage to get a prescription from their primary care doctor often spend weeks calling dozens of retail pharmacies every morning, treating the search for Wegovy like a part-time job. Even worse, the shortage of the "starter doses" (0.25mg and 0.5mg) means that new patients cannot even begin their treatment journey. For patients who have already started, a missed month of medication due to a pharmacy stock-out can result in immediate weight regain and a resurgence of "food noise"—the constant, intrusive thoughts about eating that Wegovy suppresses.

How Telehealth Compounding Actually Works: A Step-by-Step Guide

The solution to this national crisis lies in Section 503A of the Federal Food, Drug, and Cosmetic Act. Because Wegovy is officially on the FDA Drug Shortages list, the federal government allows state-licensed compounding pharmacies to step in and formulate "essentially copies" of the medication to fulfill the public health need. But how does this process actually work for the consumer?

• Step 1: The Telehealth Consultation. Instead of waiting months for an appointment with a local endocrinologist, you visit a licensed telehealth platform (like Telehealth FX). You complete a comprehensive digital medical intake, detailing your medical history, current weight, and metabolic goals.
• Step 2: Physician Review. A U.S. board-certified physician reviews your intake. If they determine that GLP-1 therapy is medically appropriate for you, they write a prescription for compounded semaglutide.
• Step 3: Pharmacy Compounding. The prescription is securely transmitted to a PCAB-accredited 503A compounding pharmacy. In a sterile, hospital-grade cleanroom (ISO Class 5), highly trained pharmacists take the raw, active pharmaceutical ingredient (base semaglutide) and formulate it into a sterile liquid injectable.
• Step 4: Third-Party Testing. Before any medication leaves the facility, the pharmacy sends a sample of the batch to an independent analytical laboratory. They use High-Performance Liquid Chromatography (HPLC) to verify that the medication is 100% pure, perfectly dosed, and completely free of bacteria or endotoxins.
• Step 5: Cold-Chain Shipping. The sterile vial of medication is packaged in an insulated cooler with frozen phase-change gel packs to ensure it remains at the required cold temperature. It is shipped overnight or via 2-day air directly to your doorstep, complete with all necessary insulin syringes and alcohol prep pads.

Understanding the Titration Schedule: Why You Start on a Low Dose

Whether you manage to find brand-name Wegovy or you transition to compounded semaglutide, your doctor will require you to follow a strict "titration schedule." This means you will not start at the maximum weight-loss dose; instead, you will start at a very low dose and gradually increase it over several months.

Why? Because semaglutide works by drastically slowing down your digestion. If you were to take the maximum dose on day one, your gastrointestinal system would go into shock, resulting in severe nausea, vomiting, and potentially hospitalization. The titration schedule allows your body to safely build a tolerance to the medication.

The standard schedule for semaglutide looks like this:

• Month 1: 0.25mg per week (The Initiation Dose)
• Month 2: 0.5mg per week
• Month 3: 1.0mg per week
• Month 4: 1.7mg per week
• Month 5+: 2.4mg per week (The Maintenance Dose)

This is where the pricing structure of telehealth platforms becomes critical. Many platforms advertise a cheap "starter" price (e.g., $199) for Month 1, but by Month 4, they double or triple the price to $400+ as your dose increases. This is why Telehealth FX is our top recommendation: they charge a flat $146 per month, regardless of your dosage. Your price never increases as you move up the titration schedule.

The Insurance Battle: Why Most Americans Are Paying Cash

If you have recently attempted to fill a prescription for Wegovy, you likely experienced a harsh reality check at the pharmacy counter. Even if the medication is miraculously in stock, your insurance provider might outright refuse to pay for it.

Currently, the vast majority of commercial health insurance plans in the United States categorize anti-obesity medications like Wegovy as "lifestyle" drugs rather than essential, life-saving medical treatments. This means they are completely excluded from standard pharmacy formularies. Furthermore, by federal law, Medicare Part D is legally prohibited from covering any medication prescribed solely for weight loss—a massive barrier that affects millions of seniors.

For the lucky few whose insurance plans do offer coverage, the bureaucratic hurdles are often insurmountable. Insurers typically require extensive "Prior Authorization" processes. They demand proof that you have actively participated in a recognized lifestyle modification program for at least six months and have a BMI over 30 (or over 27 with a related condition like high blood pressure). Even worse, many insurers utilize "step therapy," requiring you to fail on older, cheaper, and less effective generic weight loss pills before they will even consider approving Wegovy.

Because of these massive administrative roadblocks and high denial rates (often exceeding 60% on the first try), millions of patients are simply opting out of the insurance system altogether. By utilizing telehealth platforms that provide compounded semaglutide for a flat rate of $146 per month, patients bypass the insurance friction entirely, guaranteeing themselves immediate, consistent access to their medication without the stress of monthly prior authorization battles.